FDA-Drug2026-05-20Class IIPROCESSING DEFECT
Ascend Laboratories metoprolol succinate extended-release tablets recalled for failed dissolution
What this means
Ascend Laboratories is recalling one lot of metoprolol succinate extended-release 25 mg tablets because they failed to meet dissolution specifications. This means the tablets may not break down and release the medication properly in the body. The affected lot was distributed nationwide.
- Check if you take metoprolol succinate extended-release 25 mg from Ascend Laboratories (NDC 67877-590-01, lot #25140859, expiration Jan 2027).
- Contact your pharmacist or doctor if you have this medication.
- Do not stop taking your metoprolol without talking to your doctor first.
The agency's original wording
Hazard
Failed Dissolution Specifications
Intended for
Adults
Illnesses reported
None reported
Sold states
U.S. Nationwide
Affected count
17,304 100-count bottles
Manufactured in
135 Us Highway 202 206 Ste 15, Bedminster, NJ, United States
Products
Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-590-01.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0547-2026More Ascend Laboratories recalls
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.